Luciferase Stable IMR-32 Cell Line

CAT.NOUNITPRICE
T61001x106 cells / 1.0 ml
$0.00

Specifications


DescriptionLuciferase Stable IMR-32 cells are derived from primary stage 4 neuroblastoma with MYCN gene amplification (a characteristic of advanced neuroblastoma). These cells have applications in understanding more about local and metastatic tumor growth patterns and exploring new cancer therapeutics.
SKUT6100
SpeciesHuman (H. sapiens)
Tissue/Organ/Organ SystemBrain
Cell MorphologyNeuronal
ApplicationsFor Research Use Only
Seeding Density30,000 - 40,000 cells/cm2
Population Doubling Time20 hours
Donor Age13 months old
Donor DiseaseStage 4 neuroblastoma
Donor EthnicityNot disclosed
Cell TypeDrug Discovery Cell Lines
Growth PropertiesAdherent
Expression ProfileLuciferase (gene insertion); PcDNA3-Luc2 vector; neomycin resistance
Preservation Protocol1. Freeze Medium: Complete growth medium with 20% FBS and 10% DMSO.
2. Storage Temperature: Liquid nitrogen vapour phase.
Unit quantity1x106 cells / 1.0 ml
QC1) Western blot; 2) Bioluminescence; 3) Inner salt (MTS) assay
Documents


Supporting Protocol
MSDS

    QC

      Other

      FAQs


      There are no FAQs for this product yet!
      References


      There are no references for this product yet!